How to Treat Thrombosis During Pregnancy: A Guide to Safe Therapy

Pregnancy is a period of massive bodily reorganization, during which blood viscosity naturally increases. This is how nature protects the woman from dangerous hemorrhages during childbirth. However, this protective mechanism has a downside: the risk of deep vein thrombosis increases severalfold.

The diagnosis of "thrombosis" or "thrombophilia during pregnancy" often causes anxiety in expectant mothers. Many questions arise: how to treat blood clot formation in pregnant women without harming the baby? Are blood-thinning injections safe? Can serious medications be avoided?

Modern medicine allows for successful management of this problem. Timely prevention of venous thromboembolic complications (VTE) and properly selected anticoagulant therapy minimize risks for both mother and fetus. In this practical guide, we will detail how to safely treat thrombosis at different stages of gestation, which drugs are strictly prohibited, and how to properly prepare for childbirth.

Step 1: Risk Assessment and Symptom Identification (Diagnostic Stage)

Successful and safe treatment of thrombosis during pregnancy always begins with accurate and timely diagnosis. Since the load on the woman's circulatory system increases manifold during this period, it is crucial to distinguish normal leg fatigue or physiological edema from the first signs of dangerous blood stasis. Timely identification of risk factors and assessment of the clinical picture allow for prompt intervention, protecting the health of the expectant mother and baby.

The diagnostic stage requires close collaboration between specialized physicians and the patient herself. Understanding which alarming signs of the body require immediate attention and to whom to seek help immediately is the first and most responsible step toward safe and effective therapy.

How to Recognize Deep Vein Thrombosis and Its Danger to Mother and Fetus

During pregnancy, blood viscosity increases physiologically, which protects the woman from blood loss during labor, but simultaneously increases the risk of thrombosis. Recognizing deep vein thrombosis (DVT) in the early stages is vital for the safety of the mother and baby.

The main symptoms requiring immediate medical attention:

• Asymmetrical edema: one leg (more often the left) swells noticeably in the calf or thigh area.
• Pain and tightness: aching or sharp pain in the calf muscle, which worsens when walking or flexing the foot inward.
• Skin color and temperature changes: the skin over the affected vein becomes hot to the touch and takes on a reddish or bluish tint.

How dangerous is DVT? For the mother, the main risk is clot detachment and the development of life-threatening pulmonary embolism (PE). For the fetus, thrombophilia during pregnancy and impaired maternal-placental blood flow threaten placental insufficiency, developmental delay, hypoxia, and even miscarriage. Timely prevention of VTE saves two lives.

Which Doctor to Consult: The Role of the Hematologist and Obstetrician-Gynecologist in Diagnosis

If there are initial suspicions of thrombosis, there can be no delay. Treating this pathology in pregnant women requires a multidisciplinary approach, where two specialists play a key role:

• Obstetrician-Gynecologist. This is your primary coordinator. They assess general risks, monitor fetal development, placental condition, and coordinate the actions of all physicians. It is the gynecologist who first raises the alarm and refers for further examination.
• Hematologist. A specialist in the blood coagulation system. They analyze hemostasis indicators, identify genetic thrombophilia, and select the individual dosage of low molecular weight heparins. The hematologist monitors blood viscosity throughout gestation.

For precise localization of the clot, a vascular surgeon (phlebologist) is necessarily involved in the consultation, who performs duplex ultrasound scanning of the veins. This trinity of specialists allows for rapid and safe mitigation of the threat.

Step 2: Medicinal Treatment (Safe Pharmacotherapy)

Once the diagnosis is confirmed by specialized physicians, the primary task is to select a safe and effective treatment regimen. Pharmacotherapy for thrombosis in pregnant women differs fundamentally from standard protocols: the focus here is not only on restoring the mother's vascular patency but also on the absolute safety of the developing fetus. Most common anticoagulants can penetrate the placental barrier, causing severe developmental defects or bleeding.

This is why the choice of medications is strictly limited by international clinical guidelines. In this section, we will examine which drugs form the basis of safe thrombosis treatment during gestation, and which medications are strictly prohibited at any stage of pregnancy.

Low Molecular Weight Heparins (LMWH): Why Injections Are Chosen (Clexane, Frasiparin)

The gold standard for the treatment and prevention of venous thromboembolic complications (VTE) in pregnant women is low molecular weight heparin (LMWH), the most well-known representatives of which are Clexane (enoxaparin sodium) and Frasiparin (nadroparin calcium).

The main reason hematologists and obstetricians-gynecologists choose these injectable preparations is their absolute safety for the unborn child. LMWH molecules are large and have a high molecular weight, which means they are categorically unable to penetrate the placental barrier. This means the therapy does not affect fetal development and does not create a risk of bleeding in the child.

Main advantages of using LMWH:

• High efficacy: they rapidly reduce increased blood viscosity and block the growth of existing clots.
• Predictable action profile: the drugs have stable bioavailability, which minimizes the need for constant laboratory monitoring.
• Ease of use: subcutaneous injections in the abdominal area are performed with ultra-fine needles, allowing the woman to administer injections herself at home.

Prohibited Drugs: Why Warfarin and Systemic NSAIDs Are Contraindicated in Pregnancy

Unlike low molecular weight heparins, which have a large molecular mass and do not penetrate the placental barrier, some popular drugs are strictly prohibited during gestation due to a direct threat to the life and development of the fetus.

1. Warfarin (indirect-acting anticoagulant)
This drug easily crosses the placental barrier and has a pronounced teratogenic effect. Taking warfarin, especially in the first trimester (between weeks 6 and 12), leads to the development of "fetal warfarin syndrome" (embryopathy). This is a severe pathology involving nasal hypoplasia, skeletal malformations, developmental delay, and central nervous system damage. In later stages, warfarin sharply increases the risk of bleeding in the fetus and mother.

2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Drugs such as ibuprofen, diclofenac, or ketoprofen are often used to relieve pain and inflammation, but they are prohibited during pregnancy:

• In the first trimester: they increase the risk of spontaneous abortion and congenital heart defects.
• In the third trimester: they can cause premature closure of the arterial (ductus arteriosus) in the fetus, leading to pulmonary hypertension, as well as reducing amniotic fluid production (oligohydramnios) and weakening labor contractions.

All oral forms of anticoagulants and systemic analgesics must be completely excluded from the treatment regimen of a pregnant woman.

Step 3: Non-pharmacological Therapy and Lifestyle Modification

Pharmacological therapy is the foundation of combating thrombosis, but its effectiveness is reduced without changing daily habits and providing mechanical support to the veins. During pregnancy, when the growing uterus exerts constant pressure on the major vessels of the pelvis, the body critically needs external assistance. Non-pharmacological methods help physically ease blood flow from the lower extremities, naturally reduce blood viscosity, and decrease edema.

A comprehensive approach includes proper redistribution of pressure on the veins using special hosiery, as well as simple but regular actions: from monitoring fluid intake to performing safe exercises and using relieving positions. Let's examine how these basic measures help protect the vessels without placing a drug load on the fetus.

How to Properly Choose and Use Compression Stockings

Compression hosiery is the basis of non-pharmacological treatment and prevention of venous thromboembolic complications (VTE).
For pregnant women diagnosed with thrombosis or at high risk of developing it, medical stockings of Class 2 compression (pressure 20–30 mmHg) are usually prescribed. The compression class must be selected exclusively by a physician (phlebologist or obstetrician-gynecologist), as improperly chosen pressure can be harmful.

Rules for Selection and Use:

• Accurate Measurements: Take measurements in the morning, immediately upon waking, before the legs have swollen. Measurements are taken around the ankle, the widest part of the calf, and the thigh.
• Proper Application: Put on the stockings in the morning without getting out of bed. To facilitate the process and avoid damaging the hosiery, use special rubber gloves.
• Wearing Schedule: Wear the compression hosiery throughout the day, removing them only at night.
• For Labor: Special hospital (antithrombotic) stockings will be required for labor and the first days postpartum, as they ensure proper pressure distribution while lying down.

Quality hosiery effectively reduces stasis, accelerates blood flow, and protects veins from overstretching.

Physical Activity, Fluid Intake, and Relieving Positions to Improve Blood Flow

Compression hosiery works much more effectively when combined with proper physical and fluid intake regimens.

• Physical Activity. Movement is the main stimulant for venous return. Regular, calm walking for 30–40 minutes a day is beneficial for pregnant women. Walking engages the calf muscles, which act as a "muscle pump," pushing blood upward. Avoid static positions: perform light exercises every 45 minutes (foot rotations, heel-to-toe rocking).
• Fluid Intake. Adequate fluid consumption directly reduces blood viscosity. Dehydration is one of the main triggers for thrombosis. It is recommended to drink clean water at a rate of 30 ml per kg of body weight per day (if there are no contraindications from the kidneys), which serves as an important factor in VTE prevention.
• Relieving Positions. To improve blood flow, regularly rest lying on the left side—this reduces the pressure of the growing uterus on the inferior vena cava. During sleep and rest, place a pillow or roll under your legs, elevating them 15–20 cm above heart level.

Step 4: Preparing for Labor While on Continuous Anticoagulant Therapy

Transitioning from routine thrombosis monitoring to labor is a stage that requires meticulous precision from the expectant mother and the medical team. Since low molecular weight heparin (LMWH) therapy directly affects blood clotting, the delivery process must be carefully planned in advance. The main goal at this stage is to find a safe balance: protecting the woman from thromboembolic complications while minimizing the risk of massive bleeding during contractions and delivery.

Successful and safe labor in cases of thrombophilia or acute thrombosis is only possible through the coordinated interaction of the obstetrician-gynecologist, hematologist, and anesthesiologist. Let's examine how to properly prepare the body for this event without endangering yourself or the baby.

Timing and Rules for Safe Discontinuation of LMWH Before Labor and Choice of Anesthesia Method

Safe delivery while on low molecular weight heparin (LMWH) therapy requires strict adherence to time intervals. The main objective is to minimize the risk of maternal bleeding and avoid the dangerous complication of epidural hematoma during regional anesthesia.

Rules for discontinuing LMWH before labor:

• Prophylactic Dosing: The administration of the drug (e.g., Clexane or Fraxiparin) is stopped 12 hours before a scheduled Cesarean section, labor induction, or anticipated start of epidural anesthesia.
• Therapeutic Dosing: The interval between the last injection and delivery or catheter placement must be at least 24 hours.

If spontaneous labor begins before this time elapses, spinal or epidural anesthesia is contraindicated due to the risk of spinal cord compression by a hematoma. In such cases, doctors resort to alternative pain management methods or general anesthesia. Heparin injections are usually resumed 12–24 hours after delivery, provided there are no signs of active bleeding.

Features of Labor Management with Increased Thrombosis Risk

Managing labor in patients with a high risk of thrombosis requires strict control by the obstetrician-gynecologist and hematologist. Contrary to popular belief, a history of thrombophilia or thrombosis is not an automatic indication for Cesarean section. Natural birth remains the priority, as surgical intervention doubles the risk of venous thromboembolic complications (VTE).

Key rules for managing labor with increased thrombosis risk:

• Continuous Compression: The parturient must wear hospital compression hosiery throughout the entire labor process.
• Adequate Hydration: Dehydration increases blood viscosity, so maintaining fluid intake or administering intravenous infusion therapy is important.
• Prevention of Blood Stasis: Avoid prolonged motionless lying on the back. Gentle activity is welcome during the first stage of labor if possible.

If operative delivery is planned, intermittent pneumatic compression devices are additionally used during the operation and in the first hours afterward.

Step 5: Prevention and Therapy in the Postpartum Period

The birth of a child is a long-awaited moment, but for women with thrombosis or a high risk of developing it, the postpartum period requires no less vigilance than the pregnancy itself. In the first weeks after delivery, the risk of venous thromboembolic complications (VTE) increases severalfold due to sharp hormonal fluctuations, blood loss, and temporary decreased activity.

This is why anticoagulant therapy is not stopped in the delivery room. At this stage, it is crucial to correctly determine the safe timelines for continuing low molecular weight heparin (LMWH) injections and to select medications that allow the mother to protect her health without interrupting breastfeeding.

How long should heparin injections continue after childbirth

The postpartum period is a time of maximum risk for developing venous thromboembolic complications (VTE). Physiological changes in the blood clotting system, aimed at stopping postpartum bleeding, persist for several weeks after the birth of the child. This is why it is strictly forbidden to stop LMWH injections immediately after delivery.

The duration of postpartum therapy depends on the initial risks and medical history:

• Minimum course (6 weeks): Prescribed to most women who received LMWH during pregnancy due to high-risk thrombophilia or a previously experienced thrombosis. Six weeks (42 days) is a critical period during which blood clotting parameters gradually return to pre-pregnancy levels.
• Extended course (up to 3–6 months): Required if acute deep vein thrombosis developed directly during the current pregnancy or in late stages. In this case, the total period of continuous treatment (including pre-pregnancy and postpartum stages) must be at least 3–6 months.

The decision on the exact timing of stopping Clexane or Frixiparin is made exclusively by a hematologist in consultation with an obstetrician-gynecologist based on blood tests and venous ultrasounds.

Safety of Anticoagulant Therapy During Breastfeeding

Breastfeeding is not a reason to refuse vital anticoagulant therapy. Most medications used to treat and prevent postpartum thrombosis are completely safe for the infant.

• Low Molecular Weight Heparins (LMWH): Drugs such as Clexane (enoxaparin) and Frixiparin (nadroparin) are considered the "gold standard" during lactation. Due to their large molecular weight, they practically do not penetrate breast milk. Even if trace amounts enter the baby's body, they will be completely destroyed in its gastrointestinal tract by digestive enzymes.
• Warfarin: Unlike the pregnancy period, when warfarin is strictly contraindicated, its use is permitted during breastfeeding. It does not penetrate milk in its active form. Nevertheless, the therapy requires strict monitoring of the mother's INR and consultation with a hematologist.
• Direct Oral Anticoagulants (DOACs): Tablet medications (rivaroxaban, apixaban, dabigatran) are strictly prohibited during lactation. They actively penetrate breast milk and can cause bleeding in the child.

By continuing LMWH or warfarin therapy under a doctor's supervision, the woman can safely breastfeed while protecting herself from dangerous vascular complications.

Conclusion

Thrombosis treatment and prevention during pregnancy is a responsible process that requires strict discipline and close interaction with medical specialists. Modern medicine has all the necessary and safe tools to minimize risks for both mother and fetus. The main thing is to remember that a diagnosis of "thrombosis" or a predisposition to thrombophilia is not an obstacle to a healthy pregnancy and the birth of a healthy child, provided there is proper monitoring.

For a future mother to successfully navigate this path, it is important to adhere to several key rules:

• Systematic approach and discipline. Never independently stop or adjust the dosage of low molecular weight heparins (LMWH). Any changes in therapy must be agreed upon with your hematologist and obstetrician-gynecologist.
• Comprehensive approach. Combine medicinal support with non-medicinal methods: daily wearing of properly fitted compression hosiery, maintaining hydration, and moderate physical activity.
• Timely planning. Discuss the delivery tactics and the schedule for temporary discontinuation of anticoagulants with your doctor in advance so that the delivery process proceeds as safely and predictably as possible.
• Attention to the postpartum period. Remember that the risks of thrombosis persist after the baby is born. Continue prevention for exactly as long as the specialist has prescribed.

Pregnancy is a wonderful period of life, and even serious challenges like vascular pathologies are successfully overcome today thanks to evidence-based medicine. Trust your attending physicians, listen carefully to your body's signals, and remain calm—this is the key to the health of you and your baby.